Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

2 New Drugs May Help Fight Diabetes

Drugs, Called Alogliptin and Saxagliptin, Are in the Same Drug Class as Januvia
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 9, 2008 -- Two new drugs to treat type 2 diabetes fared well in their clinical trials, new research shows.

The drugs are alogliptin and saxagliptin. They're in a class of drugs called DPP-IV inhibitors, which block an enzyme called DPP-IV to keep insulin-boosting proteins in the blood longer.

The FDA approved the first DPP-IV inhibitor, Januvia, in 2006.

Alogliptin and saxagliptin are both up for the FDA's consideration. This week in Rome, researchers have been presenting their latest trials on those drugs.

The trials tracked hemoglobin A1c, which gauges blood sugar control, over two to three months in adults with type 2 diabetes.

In the saxaglpiptin trials, patients either took saxagliptin or a placebo, along with other diabetes drugs, for 24 weeks. The alogliptin trials lasted two weeks longer, with patients taking alogliptin or a placebo.

Compared to the placebo, taking alogliptin or saxagliptin in addition to other diabetes drugs led to better hemoglobin A1c levels without adding new safety concerns.

The studies didn't include a head-to-head comparison of alogliptin, saxagliptin, or Januvia.

The findings, presented in Rome at the 44th annual meeting of the European Association for the Study of Diabetes, were funded by the drugs' makers.

Alogliptin is made by Takeda Pharmaceutical Company. The drug companies Bristol Myers Squibb and AstraZeneca are collaborating on saxagliptin, which they plan to call "Onglyza" if approved.

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
jennie brand miller

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner